Analysis Of Income And Expense [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|
| Analysis of income and expense [abstract] | ||
| Revenue [abstract] | ||
| Revenue |
29,044
EUR
|
27,549
EUR
|
| Material income and expense [abstract] | ||
| Impairment loss (reversal of impairment loss) on trade receivables [abstract] | ||
| Impairment loss recognised in profit or loss, trade receivables |
79,000
EUR
|
98,000
EUR
|
| Finance income (cost) |
909,000
EUR
|
960,000
EUR
|
| Operating expense |
27,768
EUR
|
25,709
EUR
|
| Expenses by nature [abstract] | ||
| Classes of employee benefits expense [abstract] | ||
| Employee benefits expense |
16,161
EUR
|
15,135
EUR
|
| Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract] | ||
| Depreciation and amortisation expense [abstract] | ||
| Depreciation expense |
249,000
EUR
|
270,000
EUR
|
| Amortisation expense |
2,525
EUR
|
2,352
EUR
|
| Other expenses, by nature |
3,747
EUR
|
3,880
EUR
|
| Disclosure of attribution of expenses by nature to their function [text block] | — | — |
| Disclosure of attribution of expenses by nature to their function [abstract] | ||
| Disclosure of attribution of expenses by nature to their function [line items] | ||
| Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract] | ||
| Share of profit (loss) of associates and joint ventures accounted for using equity method |
81,000
EUR
|
7,000
EUR
|
| Comprehensive income, continuing and discontinued operations [abstract] | ||
| Comprehensive income |
27,000
EUR
|
688,000
EUR
|